Cell-resolved transcriptomics separates the components of a pathway- wide PI3K–AKT response in dilated cardiomyopathy: the AKT1 change localizes to cardiomyocytes, the PIK3CA change peaks in fibroblasts
Using single-nucleus RNA sequencing to overcome the limitations of bulk tissue analysis, this study reveals that the PI3K–AKT pathway response in dilated cardiomyopathy comprises distinct, cell-type-specific components—specifically an AKT1 upregulation restricted to cardiomyocytes and a PIK3CA increase peaking in fibroblasts—rather than a unified, validated therapeutic target.